tiprankstipranks
Trending News
More News >

Joseph Andrew Walewicz Insider Profile

4 Followers
Joseph Andrew Walewicz, Director at Mirati Therapeutics, holds 70.00K shares in Mirati Therapeutics (Ticker: MRTX), holds 597.19K shares in Neupath Health Inc. (Ticker: TSE:NPTH). Most recently, Joseph Andrew Walewicz ― shares of Mirati Therapeutics on ― for an estimated value of ―.
tipranks
Joseph Andrew Walewicz

Joseph Andrew Walewicz
Mirati Therapeutics (MRTX)
Director

Ranked #27,359 out of 102,674 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+8.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

C$103K
100.00%
A breakdown of Joseph Andrew Walewicz's holdings

Insider Roles

Neupath Health Inc.
(NPTH)
Chief Executive Officer
Roles that Joseph Andrew Walewicz holds in companies

Most Profitable Insider Trade

Stock:
Neupath Health Inc.
(NPTH)
Rating:Informative Buy
Date:Dec 12, 2024 - Today
Return:+31.50%
The most profitable trade made by Joseph Andrew Walewicz

Joseph Andrew Walewicz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MRTX
Mirati Therapeutics
$4.11M
Neupath Health Inc.
Apr 02, 2025
Chief Executive Officer
Informative Buy
15.38K
C$143.33K
List of latest transactions for each holding click on a transaction to see Joseph Andrew Walewicz's performance on stock

Joseph Andrew Walewicz insider profile FAQ

What is the percentage of profitable transactions made by Joseph Andrew Walewicz?
The percentage of profitable transactions made by Joseph Andrew Walewicz is 80%.
    What is the average return per transaction made by Joseph Andrew Walewicz?
    The average return per transaction made by Joseph Andrew Walewicz is 8.70%.
      What stocks does Joseph Andrew Walewicz hold?
      Joseph Andrew Walewicz holds: MRTX, TSE:NPTH stocks.
        What was Joseph Andrew Walewicz’s latest transaction?
        Joseph Andrew Walewicz latest transaction was an Uninformative Buy of ―.
          What was Joseph Andrew Walewicz's most profitable transaction?
          Joseph Andrew Walewicz’s most profitable transaction was an Informative Buy of TSE:NPTH stock on December 12, 2024. The return on the trade was 31.50%.
            What is Joseph Andrew Walewicz's role in Mirati Therapeutics?
            Joseph Andrew Walewicz's role in Mirati Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.